CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma

Genetic Variants of MicroRNA-146a and MicroRNA-196a2 are Associated with Poor Outcome but not Risk of High-Grade B- Cell Non-Hodgkin Lymphoma

Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia

Prognostic Value of Insulin-Like Growth Factor 1 in Hodgkin Lymphoma

Interleukin –1 Receptor Antagonist Gene Polymorphism and Malignant lymphomas

THE INTERPLAY BETWEEN C-MYCONCOGENE EXPRESSION AND CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR, ITS ANTAGONIST RECEPTOR, FUNS-LIKE TYROSINE KINASE 1 IN DIFFUSE LARGE B CELL LY

PROGNOSTIC FACTORS IN LOW GRADE LYMPHOMA (Study of 278 Cases)

Evaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma

DIAGNOSTIC AND PROGNOSTIC VALUE OF NOTCH-2 MUTATIONS IN DIFFUSE LARGE B CELL LYMPHOMA IN EGYPTIAN PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 4

Role of Proangiogenic Tyrosine Kinase with Immunoglobulin and Endothelial Growth Factor Homology Domains 2 Expressing Monocytes in Chronic Lymphocytic Leukemia